BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9201975)

  • 1. Human breast cancer growth inhibited in vivo by a dominant negative pleiotrophin mutant.
    Zhang N; Zhong R; Wang ZY; Deuel TF
    J Biol Chem; 1997 Jul; 272(27):16733-6. PubMed ID: 9201975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pleiotrophin stimulates fibroblasts and endothelial and epithelial cells and is expressed in human cancer.
    Fang W; Hartmann N; Chow DT; Riegel AT; Wellstein A
    J Biol Chem; 1992 Dec; 267(36):25889-97. PubMed ID: 1464602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pleiotrophin transforms NIH 3T3 cells and induces tumors in nude mice.
    Chauhan AK; Li YS; Deuel TF
    Proc Natl Acad Sci U S A; 1993 Jan; 90(2):679-82. PubMed ID: 8421705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 16-kDa fragment of pleiotrophin acts on endothelial and breast tumor cells and inhibits tumor development.
    Ducès A; Karaky R; Martel-Renoir D; Mir L; Hamma-Kourbali Y; Biéche I; Opolon P; Delbé J; Courty J; Perricaudet M; Griscelli F
    Mol Cancer Ther; 2008 Sep; 7(9):2817-27. PubMed ID: 18790762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The potential role of the heparin-binding growth factor pleiotrophin in breast cancer.
    Riegel AT; Wellstein A
    Breast Cancer Res Treat; 1994; 31(2-3):309-14. PubMed ID: 7533562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Domain structure of pleiotrophin required for transformation.
    Zhang N; Zhong R; Deuel TF
    J Biol Chem; 1999 May; 274(19):12959-62. PubMed ID: 10224041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secretion of pleiotrophin stimulates breast cancer progression through remodeling of the tumor microenvironment.
    Chang Y; Zuka M; Perez-Pinera P; Astudillo A; Mortimer J; Berenson JR; Deuel TF
    Proc Natl Acad Sci U S A; 2007 Jun; 104(26):10888-93. PubMed ID: 17578909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of the angiogenesis signaling domain in pleiotrophin defines a mechanism of the angiogenic switch.
    Zhang N; Zhong R; Perez-Pinera P; Herradon G; Ezquerra L; Wang ZY; Deuel TF
    Biochem Biophys Res Commun; 2006 May; 343(2):653-8. PubMed ID: 16554021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pleiotrophin, a multifunctional tumor promoter through induction of tumor angiogenesis, remodeling of the tumor microenvironment, and activation of stromal fibroblasts.
    Perez-Pinera P; Chang Y; Deuel TF
    Cell Cycle; 2007 Dec; 6(23):2877-83. PubMed ID: 18156802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A pleiotrophin-specific siRNA and its effect on PTEN-/- MEF241 cells].
    Hu YC; Liu ML; Li G; Huo YY; Wu DC
    Ai Zheng; 2006 Oct; 25(10):1210-5. PubMed ID: 17059762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of the mitogenic, angiogenic and tumorigenic activities of pleiotrophin by a synthetic peptide corresponding to its C-thrombospondin repeat-I domain.
    Hamma-Kourbali Y; Bernard-Pierrot I; Heroult M; Dalle S; Caruelle D; Milhiet PE; Fernig DG; Delbé J; Courty J
    J Cell Physiol; 2008 Jan; 214(1):250-9. PubMed ID: 17607711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pleiotrophin, an angiogenic and mitogenic growth factor, is expressed in human gliomas.
    Mentlein R; Held-Feindt J
    J Neurochem; 2002 Nov; 83(4):747-53. PubMed ID: 12421346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pleiotrophin stimulates tyrosine phosphorylation in NIH 3T3 and NB41A3 cells.
    Li YS; Deuel TF
    Biochem Biophys Res Commun; 1993 Sep; 195(2):1089-95. PubMed ID: 7690551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anaplastic lymphoma kinase is expressed in different subtypes of human breast cancer.
    Perez-Pinera P; Chang Y; Astudillo A; Mortimer J; Deuel TF
    Biochem Biophys Res Commun; 2007 Jun; 358(2):399-403. PubMed ID: 17490616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ribozyme-targeting reveals the rate-limiting role of pleiotrophin in glioblastoma.
    Grzelinski M; Bader N; Czubayko F; Aigner A
    Int J Cancer; 2005 Dec; 117(6):942-51. PubMed ID: 15986444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pleiotrophin can be rate-limiting for pancreatic cancer cell growth.
    Weber D; Klomp HJ; Czubayko F; Wellstein A; Juhl H
    Cancer Res; 2000 Sep; 60(18):5284-8. PubMed ID: 11016659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the human pleiotrophin gene. Promoter region and chromosomal localization.
    Li YS; Hoffman RM; Le Beau MM; Espinosa R; Jenkins NA; Gilbert DJ; Copeland NG; Deuel TF
    J Biol Chem; 1992 Dec; 267(36):26011-6. PubMed ID: 1464612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A dominant-negative pleiotrophin mutant introduced by homologous recombination leads to germ-cell apoptosis in male mice.
    Zhang N; Yeh HJ; Zhong R; Li YS; Deuel TF
    Proc Natl Acad Sci U S A; 1999 Jun; 96(12):6734-8. PubMed ID: 10359781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pleiotrophin gene expression is highly restricted and is regulated by platelet-derived growth factor.
    Li YS; Gurrieri M; Deuel TF
    Biochem Biophys Res Commun; 1992 Apr; 184(1):427-32. PubMed ID: 1373617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ribozyme targeting of the growth factor pleiotrophin in established tumors: a gene therapy approach.
    Malerczyk C; Schulte AM; Czubayko F; Bellon L; Macejak D; Riegel AT; Wellstein A
    Gene Ther; 2005 Feb; 12(4):339-46. PubMed ID: 15496960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.